doc. RNDr. Peter Kubatka, Ph.D.

2026

• Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity

  SVENTEKOVA Anita KUBATKA Peter SLANINOVÁ Iva NYKODÝMOVÁ Daniela HORNAKOVA Lubica TRBOLOVA Alexandra GONCHARENKO Vadim ŠMEJKAL Karel GOLUBNITSCHAJA Olga

  Peer-reviewed scientific article

  EPMA JOURNAL, year: 2026, DOI

• From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care

  KUBATKA Peter KAPINOVA Andrea BOJKOVA Bianka JOSEPH Vennila HORNAK Slavomir KAJO Karol BÜSSELBERG Dietrich SMEJKAL Karel GONCHARENKO Vadim MRAZOVA Barbara FÖVÉNYES Miroslava BUBNOV Rostyslav KUHN Walther CONDE-ARANDA Javier SMOKOVSKI Ivica STETKAROVA Ivana GOLUBNITSCHAJA Olga

  Peer-reviewed scientific article

  EPMA Journal, year: 2026, volume: 17, edition: 2, DOI

• Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer

  BENAMOR Amani KUBATKA Peter BÜSSELBERG Dietrich

  Peer-reviewed scientific article

  BIOMEDICINE & PHARMACOTHERAPY, year: 2026, volume: 201, DOI

• The specificity trap in routine tumor biomarker interpretation: Advancing the 3PM-based clinical decision framework to benefits of patients

  KUBATKA Peter FILKOVA Ludmila SLANINOVÁ Iva KAZDA Tomas SMEJKAL Karel BUSSELBERG Dietrich GOLUBNITSCHAJA Olga

  Peer-reviewed scientific article

  EPMA Journal, year: 2026, DOI